Association of polymorphisms of the serotonergic system with smoking initiation in Caucasians

Drug and Alcohol Dependence

Volumn 108, Issue 1-2, 2010, Pages 70-76

  Iordanidou, Maria ^a   Tavridou, Anna ^a   Petridis, Ioannis ^a,b   Kyroglou, Soultana ^b   Kaklamanis, Loukas ^c   Christakidis, Dimitrios ^b   Manolopoulos, Vangelis G ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b Academic General Hospital Alexandroupolis   (Greece)

^c ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

5 HT2C receptor gene polymorphisms; 5 HTTLPR polymorphism; Caucasians; Gender; Smoking; Smoking initiation

Indexed keywords

SEROTONIN 2C RECEPTOR; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; CAUCASIAN; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HETEROZYGOTE; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SEROTONINERGIC SYSTEM; SEX DIFFERENCE;

AGE OF ONSET; AGED; ALLELES; DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; GREECE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SMOKING; SYNAPTIC TRANSMISSION;

NICOTIANA TABACUM;

EID: 77649181106     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.11.015     Document Type: Article

References (43)

1. Audrain J., Lerman C., Gomez-Caminero A., Boyd N.R., and Orleans C.T. The role of trait anxiety in nicotine dependence. J. Appl. Biobehav. Res. 3 (1998) 29-42
2. Buckland P.R., Hoogendoorn B., Guy C.A., Smith S.K., Coleman S.L., and O'Donovan M.C. Low gene expression conferred by association of an allele of the 5-HT2C receptor gene with antipsychotic-induced weight gain. Am. J. Psychiatry 163 (2005) 613-615
3. Chu S.L., Xiao D., Wang C., and Jing H. Association between 5-hydroxytryptamine transporter gene-linked polymorphic region and smoking behavior in Chinese males. Chin. Med. J. (Engl) 122 (2009) 1365-1368
4. Collier D.A., Stobber G., Li T., Heils A., Catalano M., Bella D.D., Arranz M.J., Murray R.M., Vallada H.P., Bengel D., Müller C.R., Roberts G.W., Smeraldi E., Kirov G., Sham P., and Lesch K.P. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in the susceptibility to affective disorders. Mol. Psych. 1 (1996) 453-460
5. Cravchik A., and Goldman D. Neurochemical individuality: genetic diversity among human dopamine and serotonin receptors and transporters. Arch. Gen. Psychiatry 57 (2000) 1105-1114
6. Dani J.A., and Heinemann S. Molecular and cellular aspects of nicotine abuse. Neuron 16 (1996) 905-908
7. Di Matteo V., Di Giovanni G., Di Mascio M., and Esposito E. SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology 38 (1999) 1195-1205
8. Di Matteo V., Di Mascio M., Di Giovanni G., and Esposito E. Acute administration of amitriptyline and mianserin increases dopamine release in the rat nucleus accumbens: possible involvement of serotonin2C receptors. Psychopharmacology 150 (2000) 45-51
9. 2c receptors in the control of brain dopaminergic function. Pharmacol. Biochem. Behav. 71 (2002) 727-734
10. Di Giovanni G., De Deurwaerdere P., Di Mascio M., Di Matteo V., Esposito E., and Spampinato U. Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostratial dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience 91 (1999) 587-597
11. Gerra G., Garofano L., Saimovic A., Moi G., Branchi B., Bussandri M., Brambilla F., and Donnini C. Association of the serotonin transporter promoter polymorphism with smoking behavior among adolescents. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 135B (2005) 73-78
12. Grottick A.J., Corrigall W.A., and Higgins G.A. Activation of 5-HT2C receptors reduces the locomotor and rewarding effects of nicotine. Psychopharmacology 157 (2001) 292-298
13. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., and Lesch K.P. Allelic variation of human serotonin transporter gene expression. J. Neurochem. 66 (1996) 2621-2624
14. Henningfield J.E., and Fant R.V. Tobacco use as drug addiction: the scientific foundation. Nicotine Tob. Res. 1 Suppl 2 (1999) S31-35
15. 2c receptor gene polymorphisms associated with antipsychotic drug action alter promoter activity. Brain Res. 1149 (2007) 14-17
16. Ho M.K., and Tyndale R.F. Overview of the pharmacogenomics of cigarette smoking. Pharmacogenom. J. 7 (2007) 81-98
17. Hu S., Brody C.L., Fisher C., Gunzerath L., Nelson M.L., Sabol S.Z., Sirota L.A., Marcus S.E., Greenberg B.D., Murphy D.L., and Hamer D.H. Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior. Mol. Psychiatry 5 (2000) 181-188
18. 2C receptor is associated with type 2 diabetes in male and female Caucasians. Pharmacogen. Genom. 18 (2008) 153-159
19. Ishikawa H., Ohtsuki T., Ishiguro H., Yamakawa-Kobayashi K., Endo K., Lin Y.L., Yanagi H., Tsuchiya S., Kawata K., Hamaguchi H., and Arinami T. Association between serotonin transporter gene polymorphism and smoking among Japanese males. Cancer Epidemiol. Biomark. Prev. 8 (1999) 831-833
20. Kaiser R., Tremblay P.B., Roots I., and Brockmoller J. Validity of PCR with emphasis on variable number of tandem repeat analysis. Clin. Biochem. 35 (2002) 49-56
21. Kremer I., Bacher-Melman R., Reshef A., Broude L., Nemanov L., Gritsenko I., Heresco-Levy U., Elizur Y., and Ebstein R.P. Association of the serotonin transporter gene with smoking behavior. Am. J. Psychiatry 162 (2005) 924-930
22. Lerer E., Kanyas K., Karni O., Ebstein R.P., and Lerer B. Why do young women smoke? II. Role of traumatic life experience, psychological characteristics and serotonergic genes. Mol. Psychiatry 11 (2006) 771-781
23. Lerman C., Shields P.G., Audrain J., Main D., Cobb B., Boyd N.R., and Caporaso N. The role of serotonin transporter gene in cigarette smoking. Cancer Epidemiol. Biomark. Prev. 7 (1998) 253-255
24. Lerman C., Caporaso N.E., Audrain J., Main D., Boyd N.R., and Shields P.G. Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence. Mol. Psychiatry 5 (2000) 189-192
25. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Müller C.R., Hamer D.H., and Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 (1996) 527-531
26. Li M.D., Cheng R., Ma J.Z., and Swan G.E. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adults twins. Addiction 98 (2003) 23-31
27. Meyer J., Saam W., Mossner R., Cangir O., Ortega G.R., and Tatschner T. Evolutionary conserved microsatellites in the promoter region of the 5-hytroxytryptamine receptor 2C gene (HTR2C) are not associated with bipolar disorder in females. J. Neural. Transm. 109 (2002) 939-946
28. Mihailescu S., Palomero-Rivero M., Meade-Huerta P., Maza-Flores A., and Drucker-Colin R. Effects of nicotine and mecamylamine on rat dorsal raphe neurons. Eur. J. Pharmacol. 360 (1998) 31-36
29. Munafo M.R., Clark T., Johnstone E.C., and Walton R.T. The genetic basis for smoking behavior: A systematic review and meta-analysis. Nicotine Tob. Res. 6 (2004) 583-597
30. Pinsonneault J., and Sadee W. Pharmacogenomics of multigenic diseases: sex-specific differences in disease and treatment outcome. AAPS Pharm. Sci. 5 (2003) 5:E29
31. Pompeiano M., Palacios J.M., and Mengod G. Distribution of the serotonin 5-HT2C receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res. Mol. Brain Res. 23 (1994) 163-178
32. Rasmussen H., Bagger Y., Tanko L.B., Christiansen C., and Werge T. Lack of association of the serotonin transporter gene promoter region polymorphism, 5-HTTLPR, including rs25531 with cigarette smoking and alcohol consumption. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B (2009) 575-580
33. Reynolds G.P., Yao Z.J., Zhang X.B., Sun J., and Zhang Z.J. Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphism separately associate with positive and negative symptom response. Eur. Neuropsychopharmacol. 15 (2005) 143-151
34. Ribeiro E.B., Bettiker R.L., Bogdanov M., and Wurtman R.J. Effects of systemic nicotine on serotonin release in rat brain. Brain Res. 621 (1993) 311-318
35. Shih J.C., Zhu Q., and Chen K. Determination of transcription initiation sites and promoter activity of the human 5-HT2A receptor gene. Behav. Brain Res. 73 (1996) 59-62
36. Sieminska A., Buczkowski K., Jassem E., and Tkacz E. Lack of association between serotonin transporter gene polymorphism 5-HTTLPR and smoking among polish population: a case-control study. BMC Med. Genet. 9 (2008) 76-83
37. Smeraldi E., Serretti A., Artioli P., Lorenzi C., and Catalano M. Serotonin-transporter gene-linked polymorphic region: possible pharmacogenetic implications of rare variants. Psychiatr. Gen. 16 (2006) 153-158
38. Stam N.J., Vanderheyden P., van Alebeek C., Klomp J., de Boer T., van Delft A.M., and Olijve W. Genomic organisation and functional expression of the gene encoding the human serotonin 5-HT2C receptor. Eur. J. Pharmacol. 269 (1994) 339-348
39. Trummer O., Koppel H., Wacher T.C., Grunbacher G., Gutjahr M., Stanger O., Ramschak-Schwarzer S., Boehm B.O., Winkelmann B.R., Marz W., and Renner W. The serotonin transporter gene is not associated with smoking behavior. Pharmacogenomics J. 6 (2006) 397-400
40. Vink J.M., Smit A.B., de Geus E.J., Sullivan P., Willemsen G., Hottenga J.J., Smit J.H., Hoogendijk W.J., Zitman F.G., Peltonen L., Kaprio J., Pedersen N.L., Magnusson P.K., Spector T.D., Kyvik K.O., Morley K.I., Heath A.C., Martin N.G., Westendorp R.G., Slagboom P.E., Tiemeier H., Hofman A., Uitterlinden A.G., Aulchenko Y.S., Amin N., van Duijn C., Penninx B.W., and Boomsma D.I. Genome-wide association study of smoking initiation and current smoking. Am. J. Hum. Genet. 84 (2009) 367-379
41. Yonan A.L., Palmer A.A., and Gilliam T.C. Hardy-Weinberg disequilibrium identified genotyping error of the serotonin transporter (SLC6A4) promoter polymorphism. Psychiatr. Gen. 16 (2006) 31-34
42. Yuan X., Yamada K., Ishiyama-Shigemoto S., Koyama W., and Nonaka K. Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes. Diabetologia 43 (2000) 373-376
43. White K.J., Walline C.C., and Barker E.L. Serotonin transporters: implications for antidepressant drug development. AAPS J. 7 (2005) 421-433